Laboratorios Farmaceuticos Rovi, S.A. (BME:ROVI)
62.10
+0.70 (1.14%)
Oct 27, 2026, 12:00 PM CET
BME:ROVI Market Cap
BME:ROVI has a market cap or net worth of €3.18 billion as of October 26, 2026. It is the 4,615th most valuable company in the world and the 35th biggest in Spain. Its market cap has decreased by 3.58% in one year.
Market Cap
3.18B
Enterprise Value
3.17B
Revenue
773.05M
Global Rank
Country Rank
#35 Spain
PE Ratio
17.15
ChartMarket Cap Chart
Since December 18, 2007, BME:ROVI's market cap has increased from 356.09K to 3.18B, an increase of 891,803.78%. That is a compound annual growth rate of 61.93%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 27, 2026 | 3.18B | -2.22% |
| Dec 31, 2025 | 3.25B | 0.87% |
| Dec 31, 2024 | 3.22B | 0.22% |
| Dec 29, 2023 | 3.21B | 66.93% |
| Dec 30, 2022 | 1.92B | -53.49% |
| Dec 30, 2021 | 4.14B | 97.10% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Grifols | 6.06B |
| Almirall | 2.26B |
| Faes Farma | 1.44B |
| Pharma Mar | 1.20B |
| Clínica Baviera | 862.58M |
| Prim, S.A. | 214.30M |
| Laboratorio Reig Jofre | 211.76M |
| Oryzon Genomics | 204.91M |